All research
P21 2026-06-01 PubMed

Acr-PNAcyp4-mediated method precisely detects KRAS SNPs at 0.66 fM without thermal cycling

Precision discrimination of single nucleotide polymorphisms via chemically engineered PNA-mediated padlock probe assembly and rolling circle amplification.

Background

Accurate and sensitive detection of single nucleotide polymorphisms (SNPs) is critical for disease diagnosis and personalized medicine. Traditional methods often require sophisticated thermal cycling equipment, limiting their use in clinical and resource-limited settings. This creates a gap for simpler, highly specific, and sensitive techniques. Peptide nucleic acids (PNAs) offer high specificity and stability, making them ideal candidates for developing advanced diagnostic tools that can overcome these limitations.

Study Design

Researchers developed a fluorescent method for highly specific single nucleotide polymorphism (SNP) detection in mixed-sequence KRAS double-stranded DNA (dsDNA). The core involved selective dsDNA opening using an acridine-linked cyclopentane PNA (Acr-PNAcyp4), followed by padlock probe hybridization and rolling circle amplification (RCA). Resulting RCA products were detected via PNA molecular beacon (PNA MB) probes. The method was validated for detection limits and discrimination capability, then applied to KRAS mutation detection in colorectal cancer cells.

Results

The novel method achieved precise detection of target dsDNA at concentrations as low as 0.66 fM, demonstrating high sensitivity. It enabled effective discrimination among different mutation types in KRAS dsDNA. The high specificity was attributed to PNA-mediated strand invasion (PMSI) and ligation reactions, combined with the robust amplification of RCA technology.

The approach successfully detected KRAS mutations in colorectal cancer cells, confirming its practical utility in complex biological samples. Crucially, this method does not require sophisticated thermal cycling equipment, simplifying the diagnostic process and making it suitable for resource-limited environments. This represents a significant advancement for detecting low-abundance disease-related mutations.

Key Findings

  • Precise detection of target dsDNA at 0.66 fM.
  • Effective discrimination among different KRAS mutation types.
  • Successful detection of KRAS mutations in colorectal cancer cells.
  • Method does not require sophisticated thermal cycling equipment.
  • High specificity via PNA-mediated strand invasion (PMSI) and RCA.

Why It Matters

This novel PNA-based method offers a significant leap in accessible and precise genetic diagnostics. By eliminating the need for complex thermal cycling equipment, it paves the way for point-of-care SNP detection in diverse settings, including resource-limited environments. For clinicians and researchers, this means faster, potentially cheaper, and more decentralized screening for disease-related mutations like KRAS. The high sensitivity (0.66 fM) and specificity could enable earlier and more accurate diagnosis, ultimately improving personalized medicine strategies. This technology could transform how genetic screening is performed, making advanced diagnostics more broadly available.


pna snp-detection kras colorectal-cancer diagnostics molecular-diagnostics
Source: pubmed:42219641 · Ingested 2026-06-01 · Digest: gemini-2.5-flash